Detection of MRD typically involves the examination of tissue samples under a microscope. Techniques such as immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) are commonly used to identify specific biomarkers that are indicative of residual cancer cells. Advanced methods such as polymerase chain reaction (PCR) may also be employed to detect genetic mutations or translocations associated with cancer.
